CDER New Molecular Entity (NME) and New Biologic License Application (BLA) Filings and Approvals

 

WHAT: Listing and reviews on New Molecular Entities

WHY: Timely disclosure of drug approval to spur innovation and bring new therapies to market

HOW: Timely posting of FDA review summaries, labeling, press releases 

LEARN

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s